Noriday Nýja-Sjáland - enska - Medsafe (Medicines Safety Authority)

noriday

pfizer new zealand limited - norethisterone 0.35mg;  ;   - tablet - 0.35 mg - active: norethisterone 0.35mg     excipient: lactose monohydrate magnesium stearate maize starch povidone - noriday is indicated for oral contraception in women for whom oestrogens may not be appropriate.

DOGMATIL CAPSULE 50 mg Singapúr - enska - HSA (Health Sciences Authority)

dogmatil capsule 50 mg

sanofi-aventis singapore pte. ltd. - sulpiride - capsule - 50 mg

DOGMATIL TABLET 200 mg Singapúr - enska - HSA (Health Sciences Authority)

dogmatil tablet 200 mg

sanofi-aventis singapore pte. ltd. - sulpiride - tablet - 200 mg

BACTHECAL baclofen 10 mg/5 mL intrathecal solution for injection ampoule Ástralía - enska - Department of Health (Therapeutic Goods Administration)

bacthecal baclofen 10 mg/5 ml intrathecal solution for injection ampoule

medsurge pharma pty ltd - baclofen, quantity: 10 mg - injection, solution - excipient ingredients: sodium chloride; water for injections - baclofen solution for intrathecal injection is indicated in patients with severe chronic spasticity of spinal origin (associated with injury, multiple sclerosis, or other spinal cord diseases) or of cerebral origin who are unresponsive to orally administered antispastics (including oral baclofen) and/or who experience unacceptable side effects at effective oral doses.

BACTHECAL baclofen 10 mg/20 mL intrathecal solution for injection ampoule Ástralía - enska - Department of Health (Therapeutic Goods Administration)

bacthecal baclofen 10 mg/20 ml intrathecal solution for injection ampoule

medsurge pharma pty ltd - baclofen, quantity: 10 mg - injection, solution - excipient ingredients: water for injections; sodium chloride - baclofen solution for intrathecal injection is indicated in patients with severe chronic spasticity of spinal origin (associated with injury, multiple sclerosis, or other spinal cord diseases) or of cerebral origin who are unresponsive to orally administered antispastics (including oral baclofen) and/or who experience unacceptable side effects at effective oral doses.

BACTHECAL baclofen 0.05 mg/1 mL intrathecal solution for injection ampoule Ástralía - enska - Department of Health (Therapeutic Goods Administration)

bacthecal baclofen 0.05 mg/1 ml intrathecal solution for injection ampoule

medsurge pharma pty ltd - baclofen, quantity: 0.05 mg - injection, solution - excipient ingredients: sodium chloride; water for injections - baclofen solution for intrathecal injection is indicated in patients with severe chronic spasticity of spinal origin (associated with injury, multiple sclerosis, or other spinal cord diseases) or of cerebral origin who are unresponsive to orally administered antispastics (including oral baclofen) and/or who experience unacceptable side effects at effective oral doses.

EVRA   -(6/0.75) PATCH (EXTENDED RELEASE) Kanada - enska - Health Canada

evra -(6/0.75) patch (extended release)

janssen inc - norelgestromin; ethinyl estradiol - patch (extended release) - 6mg; 0.75mg - norelgestromin 6mg; ethinyl estradiol 0.75mg - contraceptives